Perrigo Makes Leadership Change in Rx Pharmaceuticals Segment

Perrigo Company announced the departure of Douglas Boothe, executive vice president and general manager, Rx Pharmaceuticals. John Wesolowski, senior vice president of Rx Commercial Operations, will assume the role of acting general manager, Rx Pharmaceuticals.

“John Wesolowski has the full confidence of our executive team to advance the business,” said John Hendrickson, chief executive officer, Perrigo. “He has 24 years of generic and specialty pharma experience and brings strong customer relationships, a deep understanding of our industry, and steady commercial leadership. We are conducting a thorough search process for a business leader who will focus on performance across our Rx portfolio and invest for future long-term growth. We are examining our overall Rx strategy and will continue to drive this organization to execute in the best interests of our shareholders.”

As senior vice president of Rx Commercial Operations, Mr. Wesolowski oversees Rx sales, marketing, contracts and customer service. In addition to these responsibilities, his role will now also include oversight of Rx finance and business development.